Blauvelt, A., B. Strober, R. Langley, D. Burge, L. Pisenti, M. Yassine, S. Kavanagh, C. Arendt, R. Rolleri, and K. Reich. “Safety of Certolizumab Pegol in Chronic Plaque Psoriasis: Cumulative Data Over 48 Weeks’ Exposure from Phase 3, Multicenter, Randomized, Placebo-Controlled Studies”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S16, doi:10.25251/skin.2.supp.16.